InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

- Current share price for IDX : $2.250

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$839 Change of Directors Interest Notice - Andrew Fay 5 Sep 2022 3:16PM $2.830 $2.250 fallen by 20.49%
$839 Release from Escrow 31 Aug 2022 1:24PM $2.925 $2.250 fallen by 23.08%
$839 Change of Director's Interest Notice - Jacqueline Milne 31 Aug 2022 1:17PM $2.920 $2.250 fallen by 22.95%
$839 FY22 Environment Social and Governance (ESG) Report 29 Aug 2022 8:19AM $3.130 $2.250 fallen by 28.12%
$839 Appendix 4G and Corporate Governance Statement 29 Aug 2022 8:15AM $3.130 $2.250 fallen by 28.12%
$839 FY22 Investor Presentation 29 Aug 2022 8:10AM $3.130 $2.250 fallen by 28.12%
$839 FY22 Results Announcement 29 Aug 2022 8:09AM $3.130 $2.250 fallen by 28.12%
$839 Dividend/Distribution - IDX 29 Aug 2022 8:09AM $3.130 $2.250 fallen by 28.12%
$839 Appendix 4E and Annual Report to shareholders 29 Aug 2022 8:08AM $3.130 $2.250 fallen by 28.12%
$839 2022 Annual General Meeting 5 Aug 2022 10:28AM $3.290 $2.250 fallen by 31.61%
$839 Market Update 27 Jul 2022 9:43AM $2.760 $2.250 fallen by 18.48%
$839 Initial Directors Interest Notice - Andrew Fay 18 Jul 2022 10:43AM $2.900 $2.250 fallen by 22.41%
$839 Appointment of Non-Executive Director Andrew Fay 18 Jul 2022 8:34AM $2.850 $2.250 fallen by 21.05%
$839 Cleansing Statement - Section 708A(5)(e) Notice 1 Jul 2022 4:50PM $3.000 $2.250 fallen by 25%
$839 Completion of Peloton and Horizon Radiology acquisitions 1 Jul 2022 4:47PM $3.000 $2.250 fallen by 25%
$839 Application for quotation of securities - IDX 29 Jun 2022 2:10PM $3.010 $2.250 fallen by 25.25%
$839 Appendix 2A 29 Jun 2022 12:41PM $2.980 $2.250 fallen by 24.50%
$839 Appendix 3B 29 Jun 2022 12:12PM $2.955 $2.250 fallen by 23.86%
$839 Release From Escrow 28 Jun 2022 2:07PM $3.030 $2.250 fallen by 25.74%
$839 Change in substantial holding - IDX 24 Jun 2022 9:11AM $2.940 $2.250 fallen by 23.47%
$839 Release from Escrow 15 Jun 2022 9:10AM $2.910 $2.250 fallen by 22.68%
$839 Becoming a substantial holder 27 May 2022 8:20AM $3.570 $2.250 fallen by 36.97%
$839 Proposed issue of securities - IDX 18 May 2022 8:37AM $3.690 $2.250 fallen by 39.02%
$839 Acquisition of Horizon Radiology 18 May 2022 8:30AM $3.690 $2.250 fallen by 39.02%
$839 Update on Acquisition of Peloton Radiology 18 May 2022 8:27AM $3.690 $2.250 fallen by 39.02%

301 - 325 of 784 results

Page 13 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.